EXHIBIT 99.2

 

 

 

 

 

 

 

Meglin Clinics

 

Condensed Combined Financial Statements

as of June 30, 2019 and December 31, 2018 and

for the three and six months ended June 30, 2019 and 2018

 

 

 

 

 

 

 

1

 

 

Table of Contents Pages
FINANCIAL INFORMATION  
   
Financial Statements:  
   
Condensed Combined Statements of Financial Position 3
   
Condensed Combined Statements of Operations 4
   
Condensed Combined Statements of Cash Flows 5
   
Condensed Combined Statements of Changes in Members’ Equity 6
   
Notes to Condensed Combined Financial Statements 7
   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

MEGLIN CLINICS

CONDENSED COMBINED STATEMENTS OF FINANCIAL POSITIONS

 

   (Unaudited)   
   June 30,  December 31,
   2019  2018
ASSETS          
Current assets:          
Cash and cash equivalents  $68,316   $77,133 
Prepaid expenses and other current assets   9,000    7,957 
Total current assets   77,316    85,090 
Property and equipment, net   130,649    147,350 
Franchise fees, net   29,000    33,351 
Deposits and other assets   12,270    12,270 
Total assets  $249,235   $278,061 
           
LIABILITIES AND MEMBERS' EQUITY          
Current liabilities:          
Accounts payable and accrued expenses  $56,213   $27,456 
Deferred revenue   145,043    149,521 
Other current liabilities   10,358    10,169 
Total current liabilities   211,614    187,146 
Other liabilities   49,207    53,446 
Total liabilities   260,821    240,592 
           
Commitments and contingencies (Note 4)          
           
Members' (deficit) equity   (11,586)   37,469 
Total liabilities and members' equity  $249,235   $278,061 

 

 

 

The accompanying notes are an integral part of these combined financial statements

 

 

 

3

 

 

MEGLIN CLINICS

COMBINED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

   Three Months Ended  Six Months Ended
   June 30,  June 30,
   2019  2018  2019  2018
Revenues:            
Revenues  $411,027   $362,534   $822,725   $711,752 
                     
Expenses:                    
Selling and marketing expenses   23,319    21,449    42,026    27,891 
Depreciation and amortization   10,430    11,428    21,052    22,856 
General and administrative expenses   334,923    299,301    657,628    604,731 
Total selling, general and administrative expenses   368,672    332,178    720,706    655,478 
                     
Income from operations   42,355    30,356    102,019    56,274 
                     
Other (expense) income, net   -    (74)   37,979    (665)
                     
Net income and comprehensive income  $42,355   $30,282   $139,998   $55,609 

 

 

 

 

The accompanying notes are an integral part of these combined financial statements

 

4

 

 

MEGLIN CLINICS

COMBINED STATEMENTS OF CASH FLOWS

 (Unaudited)

 

 

   Six Months Ended
   June 30,
   2019  2018
Cash flows from operating activities:          
Net income  $139,998   $55,609 
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization   21,052    22,856 
Prepaid expenses and other current assets   (42)   (32,953)
Other liabilities   23,706    - 
Deferred revenue   (4,478)   6,467 
Net cash provided by operating activities   180,236    51,979 
           
Cash flows from investing activities:          
Purchase of property and equipment   -    - 
Net cash used in investing activities   -    - 
           
Cash flows from financing activities:          
Distributions to owners   (189,053)   (45,255)
Net cash used in financing activities   (189,053)   (45,255)
           
(Decrease) Increase in cash   (8,817)   6,724 
Cash, beginning of period   77,133    39,601 
Cash, end of period  $68,316   $46,325 

 

 

 

The accompanying notes are an integral part of these combined financial statements

 

 

5

 

MEGLIN CLINICS

COMBINED STATEMENTS OF CHANGES IN MEMBERS' EQUITY (DEFICIT)

(Unaudited)

 

   Total
   members' equity (deficit)
Balances, December 31, 2017  $44,136 
Distributions to owners   (45,255)
Net income   55,609 
Balances, June 30, 2018  $54,490 
      
Balances, December 31, 2018  $37,469 
Distributions to owners   (189,053)
Net income   139,998 
Balances, June 30, 2019  $(11,586)

 

 

The accompanying notes are an integral part of these combined financial statements

 

 

6

 

MEGLIN CLINICS

 

NOTES TO COMBINED FINANCIAL STATEMENTS

 

Note 1: Nature of Operations and Summary of Significant Accounting Policies

 

Basis of Presentation and Principles of Combination

  

The accompanying Meglin Clinics condensed combined financial statements include the accounts of the following entities, all of which are under common control and ownership: TJ of Savannah – Twelve Oaks, LLC, a Georgia limited liability company (“TJS”), TJ of Pooler, LLC, a Georgia limited liability company (“TJP”), and TJ of Bluffton, LLC, a South Carolina limited liability company (“TJB”) (TJS, TJP and TJB are referred to herein collectively, as the “Company” or the “Meglin Clinics”). All significant inter-clinic accounts and transactions between the three clinics have been eliminated in combination.

 

The preparation of financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the amount of assets, liabilities, revenue, costs, expenses and other (expenses) income that are reported in the combined financial statements and accompanying disclosures. These estimates are based on management’s best knowledge of current events, historical experience, actions that the Company may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results may be different from these estimates.

 

Comprehensive Income

 

Net income and comprehensive income are the same for the three and six months ended June 30, 2019 and 2018.

  

Nature of Operations

 

The Company was formed for the purpose of owning and operating franchises for The Joint Corp. ("The Joint"), a franchisor that specializes in providing affordable, convenient, and accessible chiropractic care through licensed chiropractic professionals.

 

On July 17, 2019, the Company entered into an agreement with The Joint in which it sold substantially all of the assets of three developed franchises and terminated its franchise rights under the Company's three franchise agreements for consideration of $1,650,000.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company continually monitors its positions with, and credit quality of, the financial institutions with which it invests. The Company had no cash equivalents as of June 30, 2019 and December 31, 2018.

 

Franchise Fees

 

For each franchise purchased by the Company, a fee of $29,000 is paid to The Joint. The fees are amortized on a straight-line basis over a period of 10 years, which is the term of the franchise agreement. 

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is computed using the straight-line method over estimated useful lives of three to seven years. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or the estimated useful life of the assets. Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.

    

Long-Lived Assets

 

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. The Company looks primarily to estimated undiscounted future cash flows in its assessment of whether or not long-lived assets are recoverable. No impairments of long-lived assets were recorded for the three and six months ended June 30, 2019 and 2018.

 

7

Revenue Recognition

 

The Company earns revenues from clinics that it owns and operates, and revenues are recognized when services are performed. The Company offers a variety of membership and wellness packages which feature discounted pricing as compared with its single-visit pricing.  Amounts collected in advance for membership and wellness packages are recorded as deferred revenue and recognized when the service is performed.

   

Royalties and Advertising Fees

 

Pursuant to the franchise agreements, the Company is required to pay royalties and advertising fees based on a percentage of sales, including 7% for royalties and 2% for advertising fees. Total royalties and advertising fees for the three and six months ended June 30, 2019 were $36,664, and $74,467, respectively. Total royalties and advertising fees for the three and six months ended June 30, 2018 were $33,413, and $65,168, respectively. 

 

Advertising Costs

 

The Company expenses advertising costs as incurred. Advertising expenses for the three and six months ended June 30, 2019 were $23,319, and $42,026, respectively. Advertising expenses for the three and six months ended June 30, 2018 were $21,449, and $27,891, respectively. 

 

Income Taxes

 

The Company has elected to be treated as a limited liability company for income tax purposes. Accordingly, taxable income and losses of the Company are reported on the income tax returns of the members’, and no provision for federal income taxes has been recorded on the accompanying financial statements.

 

The Company applies a more likely than not measurement methodology to reflect the financial statement impact of uncertain tax positions taken or expected to be taken in a tax return. If taxing authorities were to disallow any tax positions taken by the Company, the additional income taxes, if any, would be imposed on the Company's members’ rather than on the Company. Accordingly, there would be no effect on the Company's financial statements.

  

Recent Accounting Pronouncements

 

Newly Issued Accounting Standards Not Yet Adopted

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 - Revenue from Contracts with Customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The standard also calls for additional disclosures around the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard will replace most existing revenue recognition guidance in GAAP when it becomes effective. The new standard becomes effective for the Company as of the acquisition date by The Joint.

 

In February 2016, the FASB issued the guidance of Accounting Standards Codification 842 – Leases (“ASC 842”). The new guidance will require lessees to recognize a right-of-use asset and a lease liability for virtually all leases, other than leases with a term of 12 months or less, and to provide additional disclosures about leasing arrangements. The Company will adopt this using the modified retrospective approach. The Company is still finalizing its adoption procedures, but it anticipates that the adoption of this standard will result in the recognition of additional right-of-use assets and lease liabilities for minimum commitments under noncancelable operating leases of approximately $425,000 as of the date of adoption.

 

The Company reviewed other newly issued accounting pronouncements and concluded that they either are not applicable to the Company's operations or that no material effect is expected on the Company's financial statements upon future adoption.

 

8

Note 2: Property and Equipment

 

Property and equipment consist of the following:

 

     June 30,
2019
     December 31,
2018
 
Leasehold improvements  $296,077   $296,077 
Furniture and fixtures   126,926    126,926 
Office equipment   65,927    65,927 
    488,930    488,930 
Less accumulated depreciation   (358,281)   (341,580)
Total property and equipment, net  $130,649   $147,350 

 

Depreciation expense was $8,255 and $16,702 for the three and six months ended June 30, 2019, respectively.

Depreciation expense was $9,253 and $18,506 for the three and six months ended June 30, 2018, respectively.

 

Note 3: Franchise fees

 

Franchise fees consist of the following:

 

     June 30,
2019
     December 31,
2018
 
Franchise fee  $87,000   $87,000 
Less accumulated amortization   (58,000)   (53,649)
Franchise fee, net  $29,000   $33,351 

 

Amortization expense related to the Company’s franchise fees were $2,175 and $4,350 for the three and six months ended June 30, 2019, respectively.

 

Amortization expense related to the Company’s franchise fees were $2,175 and $4,350 for the three and six months ended June 30, 2018, respectively.

 

Estimated amortization expense for the remainder of 2019 and subsequent years is as follows:

 

Future amortization expense   
2019 (remainder)  $4,350 
2020   8,700 
2021   8,700 
2022   6,767 
2023   483 
Total  $29,000 

 

Note 4: Commitments and Contingencies

 

Litigation

 

In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company.

 

9